Cited by 186CRISPR and Genetic EngineeringCAR-T cell therapy researchVirus-based gene therapy research

Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies

Open access
Roth, Theodore L., Li, P. Jonathan, Blaeschke, Franziska, Nies, Jasper F., Apathy, Ryan, Mowery, Cody, Yu, Ruby, Nguyen, Michelle L.T. +11 more·2020·Cell

Abstract

SUMMARY Adoptive transfer of genetically-modified immune cells holds great promise for cancer immunotherapy. CRISPR knock-in targeting can improve cell therapies, but more high-throughput methods are needed to test which knock-in gene constructs most potently enhance primary cell functions in vivo. We developed a widely adaptable technology to barcode and track targeted integrations of large non-viral DNA templates, and applied it to perform pooled knock-in screens in primary human T cells. Pooled knock-in of dozens of unique barcoded templates into the TCR-locus revealed gene constructs that enhanced fitness in vitro and in vivo. We further developed Pooled Knock-In Sequencing (PoKI-Seq), combining single-cell transcriptome analysis and pooled knock-in screening to measure cell abundance and cell state ex vivo and in vivo. This platform nominated a novel TGFβR2–41BB chimeric receptor that improved solid tumor clearance. Pooled knock-in screening enables parallelized re-writing of endogenous genetic sequences to accelerate discovery of knock-in programs for cell therapies.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.03.039

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 46 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    Expected DNA barcodes could be selectively sequenced from cells expressing the corresponding knock-in-encoded protein products.

    “We first demonstrated that expected DNA barcodes could be selectively sequenced from cells expressing the corresponding knock-in encoded protein products.”
    Quote in the paperSubstantial claim
  • Findingown data

    Sorting cells with successful HDR knock-in that co-expressed GFP or RFP strongly enriched for the appropriate DNA barcode isolated and sequenced from either gDNA or cDNA.

    “Sorting cells with successful HDR knock in (based on expression of the NY-ESO-1 TCR) that co-expressed either GFP+ or RFP+ strongly enriched for the appropriate DNA barcode isolated sequenced from either gDNA or cDNA (Figure 1C and Figure S2C–E).”
    Quote in the paperSubstantial claim
  • Findingown data

    Primers complementary to template homology arm mismatches did not show the same enrichment for correct barcodes in sorted populations.

    “However, as expected, primers complementary to the template homology arm mismatches – which should preferentially amplify non-HDR integrated templates – did not show the same enrichment for correct barcodes in the sorted populations (Figure 2E).”
    Quote in the paperSubstantial claim
  • Findingown data

    Template switching varied with the stage of library production at which constructs were pooled.

    “Template switching varied based on the stage of library production when constructs were pooled, and we chose to pool all subsequent knock-in construct libraries at the electroporation stage (Figure 1E).”
    Quote in the paperSubstantial claim
  • Findingown data

    Relative abundances of knock-in construct barcodes could be tracked over time in an expanding population of T cells cultured in IL-2.

    “Finally, we were able to readily track the relative abundances of knock-in construct barcodes over time in an expanding population of T cells cultured in interleukin 2 (IL-2).”
    Quote in the paperSubstantial claim
  • May combine two claims. 36
  • Classified as probably not a substantial claim. 13
  • May combine two claims.

    Findingown data

    The library contained large knock-in constructs ranging from 2 kb to 3 kb, and even the largest constructs were well-represented across biological replicates.

    “The library contained large knock-in constructs ranging from 2 kb to 3 kb and even the largest constructs were well-represented across these biological replicates (Figure 2B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Barcode abundance was maintained throughout expansion for all constructs, except the IL2RA-encoding construct enriched over time.

    “Barcode abundance was maintained throughout expansion for all constructs, with a notable exception of the knock-in construct encoding IL2RA, the high affinity receptor for the interleukin (IL-2), which enriched over time in culture consistent with its known roles promoting T cell fitness (Figure 2F–G).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    TGFβR2-41BB induced a transcriptional program distinct from TCF7, with higher expression of effector cytokines such as IFN-ɣ.

    “the TGFβR2–41BB knock-in induced a distinct transcriptional program compared to TCF7 knock-in cells, with higher expression of effector cytokines such as IFN-ɣ that could enhance tumor clearance.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Both TCF7 and TGFβR2-41BB increased expression of TNFSFR9 (4-1BB) relative to control cells.

    “While both TCF7 and TGFβR2–41BB promoted expression of genes such as TNFSFR9 (4–1BB) relative to control cells”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Findingnone given

    Barcodes could be sequenced from either cDNA or genomic DNA.

    “Barcodes could be sequenced from either cDNA or genomic DNA”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    With excessive stimulation, TCF7 slightly increased cell abundance, but this effect did not reach statistical significance.

    “With excessive stimulation, which partially mirrors antigenic abundance in tumor environments, the transcription factor TCF7 (encoding the protein TCF1) slightly increased cell abundance, although this effect did not reach statistical significance (Figure S4B).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Cells with TGFβR2-41BB were the only ones that cleared the solid tumor model at the tested doses, and this was reproducible in many mice from four human blood donors.

    “Cells with the TGFβR2–41BB construct were the only ones that successfully cleared the solid tumor model at the doses tested here, an effect that was reproducible in many of the mice tested with modified T cells from 4 human blood donors (Figure 7B–C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The anti-apoptotic FAS-41BB chimera and anti-suppressive TGFβR2-41BB chimera both promoted context-dependent increased expansion relative to controls.

    “Indeed, the anti-apoptotic FAS-41BB chimera and anti-suppressive TGFβR2–41BB chimera both promoted context-dependent increased expansion relative to controls (Figure 4C and Figure S5B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Clustering of knock-in constructs across all genes differentially expressed in the identified single cell clusters showed strong similarity between the TGFβR2-derived constructs in the presence of TGFβ and revealed downstream target genes modulated by the receptors.

    “Clustering of knock-in constructs across all genes differentially expressed in the identified single cell clusters showed strong similarity between the TGFβR2-derived constructs in the presence of TGFβ and revealed downstream target genes that are modulated by the receptors.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    TCF7 was relatively enriched in CCR7+ tumor-infiltrating lymphocytes, whereas TGFβR2-41BB was relatively enriched in IL-2+ and IFNG+ TIL populations.

    “Strikingly, the TCF7 construct was relatively enriched in CCR7+ TILs, while TGFβR2–41BB was relatively enriched in both IL-2+ and IFNG+ TIL populations (Figure 6D).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingcitation

    Droplet doublets could appear as multiple barcode calls, but the predicted doublet rate of about 2% would account for only a fraction of cells with more than one barcode.

    “Droplet doublets could also appear as multiple barcode calls, but the predicted doublet rate of ~2% (Zheng et al., 2017) would account for only a fraction of the cells with more than one barcode.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Zheng et al., 2017 source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    Single-cell transcriptomes showed high overlap between cells from two human donors and marked differences between ex vivo expanded input T cells and tumor-infiltrating T cells, including differential expression of proliferation- or effector-function genes.

    “A UMAP representation of the single cell transcriptomes showed a high degree of overlap between cells from two human donors and marked differences between the ex vivo (input) cell population and tumor infiltrating (in vivo) T cells including differential expression of genes associated with proliferation or effector function (Figure 6C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Over 40,000 individual cells were sequenced, of which about 58% were successfully assigned one or two barcodes.

    “Over 40,000 individual cells were sequenced, of which ~58% were successfully assigned one (monoallelic) or two (biallelic) barcodes (Figure 5F).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    T cells engineered with a polycistronic NY-ESO-1 TCR construct plus control tNGFR, TCF7, or TGFβR2-41BB all significantly reduced tumor size compared with vehicle injections.

    “T cells engineered with a polycistronic knock-in construct expressing a NY-ESO-1 specific TCR (1G4 clone) along with either a control construct (tNGFR), the transcription factor TCF7, or the chimeric TGFβR2–41BB receptor all showed statistically significant reductions in tumor size relative to vehicle only injections of media (Figure 7B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Both TCF7 and TGFβR2-derived synthetic receptors increased T cell abundance in solid tumors but induced different cell states.

    “While both the transcription factor TCF7 and TGFβR2-derived synthetic receptors increased T cell abundance in solid tumors, they induced different cell states.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The integrated pooled knock-in platform nominated a lead hit, TGFβR2-41BB, that increased T cell fitness in vivo and promoted key effector cytokines including IFNɣ.

    “Our integrated pooled knock-in platform nominated a lead hit (TGFβR2–41BB) that increased T cell fitness in vivo and promoted key effector cytokines including IFNɣ.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Surface and intracellular staining of cells with eight individual knock-in constructs revealed robust expression for each expected protein, including increased expression of Fas and CD25 (IL2RA) above endogenous levels in stimulated T cells.

    “Surface and intracellular staining of cells with eight individual knock-in constructs revealed robust expression for each expected protein, including increased expression of Fas and CD25 (IL2RA) above endogenous expression levels in stimulated T cells (Figure 4B and Figure S5A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Across four human donors, several knock-in constructs caused statistically significant accumulation of engineered T cells in the tumor environment in vivo, including one construct not found in vitro.

    “Nonetheless, across four individual human donors, several knock-in constructs promoted statistically significant in vivo accumulation of engineered T cells in the tumor environment (Figure 6B), including a construct not identified in the in vitro screens.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Next-generation T cell therapies are being engineered with transgenes designed to overcome suppressive signals in the tumor environment.

    “Next-generation T cell therapies are being engineered with transgenes designed to overcome suppressive signals in the tumor environment (Kloss et al., 2018; Lynn et al., 2019; Yamamoto et al., 2019).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Kloss et al., 2018 source

      Not checked in the free run.

    • cites Lynn et al., 2019 source

      Not checked in the free run.

    • cites Yamamoto et al., 2019 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Antigen-specific human T cells can be produced ex vivo by non-targeted viral transduction of defined TCRs, CARs, or other synthetic receptors.

    “Antigen-specific human T cells can be generated ex vivo by non-targeted viral transduction of defined T cell receptors (TCRs), chimeric antigen receptors (CARs), or other synthetic receptors (Esensten et al., 2017).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Esensten et al., 2017 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Fas is a TNF super family surface receptor that mediates apoptosis through interactions with its ligand, FASL.

    “Fas is a TNF super family surface receptor that mediates apoptosis through interactions with its ligand, FASL (Strasser et al., 2009).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Strasser et al., 2009 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    CRISPR-Cas9 ablation of checkpoint targets such as PD-1 in adoptive T cell therapies has shown increased functionality in certain models and is being pursued clinically.

    “CRISPR-Cas9 genetic ablation of checkpoint targets such as PD-1 in adoptive T cell therapies has also shown increased functionality in certain models and is being persued clinically (Ren et al., 2017; Rupp et al., 2017; Stadtmauer et al., 2020; Su et al., 2016).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Ren et al., 2017 source

      Not checked in the free run.

    • cites Rupp et al., 2017 source

      Not checked in the free run.

    • cites Stadtmauer et al., 2020 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Genome-scale pooled CRISPR loss-of-function screens allow forward genetic studies in many mammalian cell types, including primary T cells, where they have identified genes that may be targeted in future immunotherapies.

    “Genome-scale pooled CRISPR loss-of-function screens now allow forward genetic studies in many mammalian cell types (Wang et al., 2014; Shalem et al., 2014) including primary T cells where they have identified genes that may be targeted in future immunotherapies (Dong et al., 2019; Shifrut et al., 2018; Wei et al., 2019).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Wang et al., 2014 source

      Not checked in the free run.

    • cites Shalem et al., 2014 source

      Not checked in the free run.

    • cites Dong et al., 2019 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    Large pooled knock-in libraries can be generated and their barcodes quantitatively sequenced in a human T cell population.

    “These results showed large pooled knock-in libraries can be generated and their barcodes can be quantitatively sequenced in a human T cell population.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Genetically engineered immune cell therapies are effective for some cancer types but still cannot cure most tumors.

    “Genetically engineered immune cell therapies have proven effective for treatment of some cancer types (Esensten et al., 2017; Fesnak et al., 2016; June and Sadelain, 2018; Sadelain et al., 2017), but they still cannot cure most tumors.”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Esensten et al., 2017 source

      Not checked in the free run.

    • cites Fesnak et al., 2016 source

      Not checked in the free run.

    • cites June and Sadelain, 2018

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The data suggest TCF7 promotes a more naïve or quiescent state, while TGFβR2-41BB promotes accumulation of cells expressing key effector cytokine genes.

    “These data suggest that TCF7 promotes a more naïve or quiescent state, whereas the TGFβR2–41BB construct promotes accumulation of cells expressing key effector cytokine genes.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    This allowed screening for constructs that increased cell abundance under different in vitro and in vivo selective pressures and high-dimensional analysis of cellular phenotypes resulting from each large knock-in DNA cassette.

    “This allowed us not only to screen for constructs that increased cell abundance with different in vitro and in vivo selective pressures, but also to perform high dimensional analysis of the cellular phenotypes resulting from each large knock-in DNA cassette.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In mouse chronic viral infection and syngeneic tumor models, TCF7+ cells have greater proliferative potential and less differentiated phenotypes during immunotherapy.

    “Consistent with this model, in mouse chronic viral infection and syngeneic tumor models, TCF7+ cells have increased proliferative potential and less differentiated phenotypes during immunotherapies (Kurtulus et al., 2019; Siddiqui et al., 2019; Wu et al., 2016)”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Kurtulus et al., 2019 source

      Not checked in the free run.

    • cites Siddiqui et al., 2019 source

      Not checked in the free run.

    • cites Wu et al., 2016

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    The paper presents a new CRISPR platform to test large knock-in candidate therapeutic constructs in primary human cells, which should accelerate development of improved cellular therapies.

    “In contrast to these technologies that have shown promise for screening small mutations in immortalized cells lines, we now present a new CRISPR platform to test large knock-in candidate therapeutic constructs in primary human cells, which should accelerate the development of improved cellular therapies.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Technical challenges have limited CRISPRa applications in therapeutically relevant primary human cell types.
    • Rests on an assumption: CRISPRa can only induce natural gene products encoded in the genome and does so with variable efficiency.
  • May combine two claims.

    Premisecitation

    Lentiviral and retroviral vectors have variable integration copy numbers and integrate at semi-random genome sites, which can cause variable transgene expression and altered cell phenotypes through insertional mutagenesis.

    “These vectors have variable integration copy numbers and integrate at semi-random genome sites, which can cause variability in transgene expression and altered cell phenotypes due to insertional mutagenesis (Cavazzana-Calvo et al., 2010; Romero et al., 2013).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Cavazzana-Calvo et al., 2010 source

      Not checked in the free run.

    • cites Romero et al., 2013

      Not checked in the free run.

  • May combine two claims.

    Study design and conductown data

    Quality control metrics following PoKI-Seq confirmed robust rates of gene and UMI identification per cell and an average >130X coverage of cells assigned to each knock-in construct.

    “Quality control metrics following PoKI-Seq confirmed robust rates of gene and UMI identification per cell and an average >130X coverage of cells assigned to each knock-in construct (per blood donor and per ex vivo condition tested) (Figure S6B–C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    TGFβ is a key suppressive cytokine normally produced by immune cells but can be co-opted by tumors to suppress effective immune responses.

    “TGFβ is a key suppressive cytokine normally produced by immune cells but which can be co-opted by tumors to suppress effective immune responses (Batlle and Massagué, 2019; Gigante et al., 2012).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Batlle and Massagué, 2019

      Not checked in the free run.

    • cites Gigante et al., 2012 source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Interpretationreasoning

    Barcoded knock-in libraries have broad potential to study functional effects of sequence variation at any selected site in the genome.

    “Barcoded knock-in libraries have even broader potential to study functional effects of sequence variation at any selected site in the genome.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    Pooled non-viral HDR templates allow targeted integration at a defined site with relatively consistent transgene expression and low rates of barcode mis-assignment without viral packaging.

    “In contrast to lentiviral and retroviral transgenesis, pooled non-viral HDR templates allow for targeted integration at a defined site with relatively consistent transgene expression levels and low rates of barcode mis-assignment without requiring viral packaging steps.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: A major challenge to quantitative tracking of targeted genomic integrations of pooled knock-in constructs has been the abundance of non-integrated DNA templates in targeted cells and the risk of template switching during molecular steps of pooled library production, integration, and sequencing.
  • May combine two claims.

    Premisecitation

    Lentiviral and retroviral library preparation is laborious and can lead to significant barcode swapping due to viral recombination.

    “In addition, lentiviral and retroviral library preparation is laborious and can lead to significant barcode swapping due to viral recombination (Sack et al., 2016).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Sack et al., 2016 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductcitation

    All samples were processed together in one experiment, so sample origin was not regressed out.

    “Of note, all samples were processed simultaneously in the same experiment and thus sample origin was not regressed out (Butler et al., 2018).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Butler et al., 2018 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Fresh blood was taken from healthy human donors under a protocol approved by the UCSF Committee on Human Research (CHR #13-11950).

    “Fresh blood was taken from healthy human donors under a protocol approved by the UCSF Committee on Human Research (CHR #13–11950).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    With the design parameters of the pooled knock-in library (roughly 400 bp separating the unique insert from its barcode, with the knocked-in TCR-α specificity between them), predicted switching was about 50% for pooled assembly and about 10% for pooled electroporation.

    “With the parameters of the pooled knock-in library design (~400 bps between unique library insert and its corresponding barcode, separated by the new knocked in TCR-α specificity) described here (Figure 1B), the amount of predicted template switching with pooled assembly reactions was ~50%, and with a pooled electroporation condition was only ~10%.”
    Quote in the paperSubstantial claim
    • The authors state this as an assumption: Template switching is random, and any barcode that is swapped is equally likely to switch to any other barcode.
    • The authors state this as an assumption: A template that has switched once is equally likely to switch again.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Only cells with more than 500 detected genes were included in downstream analyses.

    “Only cells with more than 500 genes identified were used for downstream analyses.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    All animal experiments complied with relevant ethical regulations under an approved IACUC protocol, including a 2.0 cm tumor size limit.

    “All animal experiments were performed in compliance with relevant ethical regulations per an approved IACUC protocol (UCSF), including a tumor size limit of 2.0 cm in any dimension.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    For 1000 sorted knock-in-positive cells, 75% are predicted to have a monoallelic knock-in (750 cells, 750 alleles) and 25% a biallelic knock-in (250 cells, 500 alleles).

    “Given 1000 sorted knock-in positive cells, 75% will possess a monoallelic knock-in (750 cells, 750 knock-in alleles), while 25% will possess biallelic knock-ins (250 cells, 500 knock-in alleles).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Investigators were blinded to experimental treatment group during tumor sizing measurements.

    “Investigators were blinded to experimental treatment group during sizing measurements.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    Reads seen fewer than twice and cells assigned more than two knock-in barcodes were removed.

    “We filtered out reads appearing less than twice and cells with more than two assigned knock-in barcodes.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    In a two-member library, half of actual template switching involves another template with the same barcode and is undetected, so the observed switching rate must be doubled.

    “In a two-member library half of the actual template switching will occur with another template that contains the same barcode, and is thus not detected. Therefore, the observed amount of switching must be multiplied by 2.”
    Quote in the paperSubstantial claim
    • The authors state this as an assumption: Template switching is random, and any barcode that is swapped is equally likely to switch to any other barcode.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    In each screen, donor replicates were combined for statistical analysis to address biological noise.

    “All donor replicates in each screen were grouped for statistical analysis to account for biological noise.”
    Quote in the paperNot a substantial claim
45 of 45
  • The paper relies on this without support.

    The field lacks rapid methods to test and directly compare the functions of large DNA knock-in integrations in human primary cells.

    “However, to date we have lacked rapid methods to test and directly compare the functions of large DNA knock-in integrations in human primary cells, which would accelerate the development of more effective cell therapies.”
  • The paper relies on this without support.

    Cell abundance alone is insufficient to assess cellular function, and an ideal screening method should also assess modified cell states.

    “However, cell abundance measures only one aspect of cellular function, and an ideal screening methodology would allow systematic assessment of modified cell states as well.”
  • The paper relies on this without support.

    The in vitro conditions used in the pooled screens mimic aspects of tumor microenvironments.

    “we repeated the pooled screen in diverse in vitro conditions designed to mimic aspects of tumor micro-environments”
  • The paper relies on this without support.

    CAR T cells have not proved effective for solid tumors.

    “CAR T cells are now approved therapy for some hematological malignancies, but have not proved effective for solid tumors.”
  • The paper relies on this without support.

    For many clinical applications, engineering antigen specificity alone will not be sufficient to cure disease.

    “Mounting evidence suggests that for many clinical applications engineering antigen specificity will not be sufficient to cure disease.”
  • The paper relies on this without support.

    T cell function is often suppressed by tumors, and further engineering of antigen-specific T cells is required to promote more effective cell states.

    “For example, T cell function is often suppressed by tumors and further engineering of antigen-specific T cells will be required to promote more effective cell states.”
  • The paper relies on this without support.

    The field needs a systematic approach to compare complex transgene constructs head-to-head and determine which are most effective for specific disease indications.

    “The field needs a systematic approach to compare complex transgene constructs head-to-head and determine which are most effective for specific disease indications.”
  • The paper relies on this without support.

    Technical challenges have limited CRISPRa applications in therapeutically relevant primary human cell types.

    “Technical challenges have limited CRISPRa applications in therapeutically relevant primary human cell types.”
  • The paper relies on this without support.

    CRISPRa can only induce natural gene products encoded in the genome and does so with variable efficiency.

    “Furthermore, CRISPRa can only induce natural gene products encoded in the genome and does so with variable efficiency.”
  • The paper relies on this without support.

    A major challenge to quantitative tracking of targeted genomic integrations of pooled knock-in constructs has been the abundance of non-integrated DNA templates in targeted cells and the risk of template switching during molecular steps of pooled library production, integration, and sequencing.

    “A major challenge to quantitative tracking of targeted genomic integrations of pooled knock-in constructs has been the abundance of non-integrated DNA templates (viral or non-viral) in targeted cells and the risk of template switching during molecular steps of pooled library production, integration, and sequencing.”
  • The paper relies on this without support.

    Most over-expression studies have been performed with lentiviral or retroviral vectors.

    “Most over-expression studies have been performed with lentiviral or retroviral vectors.”
  • The authors state this as an assumption.

    Template switching is random, and any barcode that is swapped is equally likely to switch to any other barcode.

    “Assumption 1: Template switching is random, and any barcode that is swapped is equally likely to switch to any other barcode.”
  • The authors state this as an assumption.

    A template that has switched once is equally likely to switch again.

    “Assumption 2: A template that has switched once is equally likely to switch again.”
  • The authors state this as an assumption.

    The knock-in library is arbitrarily large.

    “assuming an arbitrarily large knock-in library”
14 of 14

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Cancer-cell clearance ratio is interpreted backward

    Major

    Dividing control-cell clearance by experimental-cell clearance makes a value above 1 mean the experimental cells cleared fewer cancer cells than the control cells, not more. This reverses the stated interpretation of the assay's outcome.

  • PoKI-Seq library and processing versions conflict

    Minor

    The PoKI-Seq methods specify v3 single-cell chemistry and Cell Ranger 3.0.2, while the PoKI-Seq analysis describes V2 libraries processed with CellRanger 2.0.0. The text does not distinguish separate datasets that would account for these differing specifications.

  • In vivo PoKI-Seq cites the wrong method figure

    Minor

    The in vivo account points to Figure 4A for combined single-cell amplicon and RNA sequencing, while the paper introduces that PoKI-Seq method at Figure 5A.

3 of 3

Cites

Flagged first, then by citations

2 of the 77 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Roth, T. L., Li, P. J., Blaeschke, F., Nies, J. F., Apathy, R., Mowery, C., Yu, R., Nguyen, M. L. T., Lee, Y., Truong, A., Hiatt, J., Wu, D., Nguyen, D. N., Goodman, D., Bluestone, J. A., Ye, C. J., Roybal, K., Shifrut, E., & Marson, A.
Affiliations
University of California, San Francisco (US)
Corresponding author
  • Roth, Theodore L.
  • Marson, Alexander
Venue
Cell
Publisher
Elsevier BV
Published
2020-04
Volume
181
Issue
3
Pages
728-744.e21
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3017040524
Cited by
186
References
77
Citations by year
2026: 11 · 2025: 23 · 2024: 25 · 2023: 29 · 2022: 45 · 2021: 32 · 2020: 19 · 2019: 1
FWCI
10.13
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
T cell engineering, adoptive immunotherapy, barcoding, single-cell transcriptomics, cancer immunotherapy
MeSH terms
RNA, Guide, CRISPR-Cas Systems, Animals, Blood Cells, Genetic Engineering, Humans, Immunotherapy, T-Lymphocytes, Mice, SCID, Mice, Inbred NOD, Mice, Gene Knock-In Techniques, Single-Cell Analysis, Transcriptome, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review